Ireland
--:--IST
Latest
Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns Project Management Failures: Lessons for Healthcare FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli WeBuild Programme: 50+ Women-Led Ventures and How to Apply Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns Project Management Failures: Lessons for Healthcare FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli WeBuild Programme: 50+ Women-Led Ventures and How to Apply Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing
Priya Life Science Medicines register
Registers Clinical trials Drugs API
Registers› Irish medicines ›hameln pharma gmbh
Medicines register · Ireland

hameln pharma gmbh — licensed medicines

16 medicines held by hameln pharma gmbh on the Irish market, from the HPRA register.

Download CSV
Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,296 authorised products are in this register. Synced 07 Oct 2026, 03:23 UTC
Narrow the register Reset
Matches brand name, active substance, licence holder and licence number.
Browse by first letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
16 of 10,296 medicines
Download
Medicine
Active substance
Licence holder
Status
Cefotaxime hameln 1 g powder for solution for injection/infusion PA2237/008/001
Cefotaxime sodium
hameln pharma gmbh
Not marketed
Cefotaxime hameln 2 g powder for solution for injection/infusion PA2237/008/002
Cefotaxime sodium
hameln pharma gmbh
Not marketed
Ceftazidime hameln 1 g powder for solution for injection/infusion PA2237/010/002
Ceftazidime pentahydrate
hameln pharma gmbh
Not marketed
Ceftazidime hameln 2 g powder for solution for injection/infusion PA2237/010/003
Ceftazidime pentahydrate
hameln pharma gmbh
Not marketed
Ceftazidime hameln 500 mg powder for solution for injection PA2237/010/001
Ceftazidime pentahydrate
hameln pharma gmbh
Not marketed
Ceftriaxone hameln 1 g powder for solution for injection/infusion PA2237/011/001
Ceftriaxone sodium
hameln pharma gmbh
Not marketed
Ceftriaxone hameln 2 g powder for solution for injection/infusion PA2237/011/002
Ceftriaxone sodium
hameln pharma gmbh
Not marketed
Clarithromycin 500 mg powder for concentrate for solution for infusion PA2237/003/001
Clarithromycin
hameln pharma gmbh
Not marketed
Daptomycin 350 mg powder for solution for injection/infusion PA2237/005/001
Daptomycin
hameln pharma gmbh
Not marketed
Daptomycin 500 mg powder for solution for injection/infusion PA2237/005/002
Daptomycin
hameln pharma gmbh
Not marketed
Dexamethasone Phosphate 4 mg/ml solution for injection PA2237/004/001
Dexamethasone sodium phosphate
hameln pharma gmbh
Not marketed
Furosemide 10 mg/ml solution for injection/infusion PA2237/002/001
Furosemide
hameln pharma gmbh
Not marketed
Oxycodone hydrochloride 10mg/ml solution for injection or infusion PA2237/001/001
OXYCODONE HYDROCHLORIDE
hameln pharma gmbh
Not marketed
Vancomycin 1000 mg powder for concentrate for solution for infusion PA2237/007/002
VANCOMYCIN HYDROCHLORIDE
hameln pharma gmbh
Not marketed
Vancomycin 500 mg powder for concentrate for solution for infusion PA2237/007/001
VANCOMYCIN HYDROCHLORIDE
hameln pharma gmbh
Not marketed
Voriconazole 200mg powder for solution for infusion PA2237/006/001
Voriconazole
hameln pharma gmbh
Not marketed
Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 7 October 2026. https://priyalifescience.com/medicines/company/hameln-pharma-gmbh

Download this register
GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →
Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.